Literature DB >> 30171379

Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis.

Ferhat Demir1, Alper Han Çebi2, Mukaddes Kalyoncu3.   

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood, yet its etiology is unknown. It is known that microribonucleic acids (miRNAs) play a role in immunoregulation. We aimed to evaluate the plasma expression of some candidate miRNAs that are associated with the pathogenesis of autoimmunity. Thirty-one patients diagnosed with JIA and age-sex-matched 31 healthy children were enrolled for the study. The plasma levels of four candidate miRNAs (miRNA-16, miRNA-155, miRNA-204, and miRNA-451), which are known to be associated with autoimmunity, were examined in all the subjects. The plasma levels of miRNAs were measured with real-time PCR in the patients in active and inactive periods and in the healthy controls. The groups were compared with each other. The plasma miRNA-155 levels were found to increase in the JIA patients compared to the healthy controls, and it was statistically more significant in the inactive period. We found that the JIA patients had the higher levels of miRNA-16 and the lower levels of miRNA-204/miRNA-451 expressions compare with the control group, but there was no statistically significant difference. A statistically significant decrease in the plasma levels of miRNA-204 was found in the patients that were in inactive disease with only methotrexate therapy. The plasma miRNA expressions were compared in the JIA subtypes, and it was observed that miRNA-204 levels were higher in polyarticular JIA and miRNA-451 levels were higher in enthesitis-related arthritis without statistical significance. The significant alterations in the plasma expression of miRNA-155 and miRNA-204 suggest to us that these molecules may be related to the pathogenesis of JIA. More comprehensive and functional researches about the role of these molecules are needed in this regard.

Entities:  

Keywords:  Juvenile idiopathic arthritis; MiRNA-155; MiRNA-16; MiRNA-204; MiRNA-451; MicroRNAs

Mesh:

Substances:

Year:  2018        PMID: 30171379     DOI: 10.1007/s10067-018-4277-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

Review 1.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

2.  Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.

Authors:  Yasuko Kamiya; Jun-ichi Kawada; Yoshihiko Kawano; Yuka Torii; Shinji Kawabe; Naomi Iwata; Yoshinori Ito
Journal:  Clin Rheumatol       Date:  2015-04-07       Impact factor: 2.980

3.  Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.

Authors:  Nóra Judit Béres; Zoltán Kiss; Zsófia Sztupinszki; Gábor Lendvai; András Arató; Erna Sziksz; Ádám Vannay; Attila J Szabó; Katalin Eszter Müller; Áron Cseh; Kriszta Boros; Gábor Veres
Journal:  Dig Liver Dis       Date:  2016-12-27       Impact factor: 4.088

4.  Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.

Authors:  Lei Ma; Xubin Deng; Minhua Wu; Gong Zhang; Jianqing Huang
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

5.  miR-451 regulates dendritic cell cytokine responses to influenza infection.

Authors:  Carrie M Rosenberger; Rebecca L Podyminogin; Garnet Navarro; Guo-Wei Zhao; Peter S Askovich; Mitchell J Weiss; Alan Aderem
Journal:  J Immunol       Date:  2012-11-19       Impact factor: 5.422

6.  Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis.

Authors:  Koichi Murata; Hiroyuki Yoshitomi; Shimei Tanida; Masahiro Ishikawa; Kohei Nishitani; Hiromu Ito; Takashi Nakamura
Journal:  Arthritis Res Ther       Date:  2010-05-14       Impact factor: 5.156

Review 7.  The role of miRNA in inflammation and autoimmunity.

Authors:  Ram Pyare Singh; Israel Massachi; Sudhir Manickavel; Satendra Singh; Nagesh P Rao; Sascha Hasan; Deborah K Mc Curdy; Sherven Sharma; David Wong; Bevra H Hahn; Hamida Rehimi
Journal:  Autoimmun Rev       Date:  2013-07-14       Impact factor: 9.754

Review 8.  MicroRNAs in the DNA Damage/Repair Network and Cancer.

Authors:  Alessandra Tessitore; Germana Cicciarelli; Filippo Del Vecchio; Agata Gaggiano; Daniela Verzella; Mariafausta Fischietti; Davide Vecchiotti; Daria Capece; Francesca Zazzeroni; Edoardo Alesse
Journal:  Int J Genomics       Date:  2014-01-30       Impact factor: 2.326

9.  Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs.

Authors:  Xiaochuan Li; Feng Tian; Fei Wang
Journal:  Int J Mol Sci       Date:  2013-12-09       Impact factor: 5.923

10.  The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis.

Authors:  Ning-Sheng Lai; Hui-Chun Yu; Chien-Hsueh Tung; Kuang-Yung Huang; Hsien-Bin Huang; Ming-Chi Lu
Journal:  Arthritis Res Ther       Date:  2017-12-01       Impact factor: 5.156

View more
  4 in total

Review 1.  Epigenetic regulation of pediatric and neonatal immune responses.

Authors:  Jennifer Bermick; Matthew Schaller
Journal:  Pediatr Res       Date:  2021-07-08       Impact factor: 3.756

2.  Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis.

Authors:  Olivier Fogel; Andreas Bugge Tinggaard; Maud Fagny; Nelly Sigrist; Elodie Roche; Laurence Leclere; Jean-François Deleuze; Frederic Batteux; Maxime Dougados; Corinne Miceli-Richard; Jörg Tost
Journal:  Arthritis Res Ther       Date:  2019-02-12       Impact factor: 5.156

Review 3.  Functional Regulation of Macrophage Phenotypes by MicroRNAs in Inflammatory Arthritis.

Authors:  Xiaoling Niu; Grant S Schulert
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

Review 4.  The role of epigenetics in childhood autoimmune diseases with hematological manifestations.

Authors:  Athanasios Gkoutsias; Alexandros Makis
Journal:  Pediatr Investig       Date:  2022-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.